SPRINGHILL FUND ASSET MANAGEMENT (HK) CO LTD
Latest 13F filing data - Q1 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | SMMT | 124K | $2.40M |
 | JANX | 79K | $2.12M |
 | COGT | 29K | $176.65K |
 | AKRO | 20K | $806.56K |
 | SLNO | 20K | $1.42M |
 | INSM | 19K | $1.46M |
 | PTGX | 13K | $621.86K |
 | REGN | 3K | $1.65M |
 | ASND | 2K | $338.68K |
 | LLY | 816 | $673.94K |
Summit Therapeutics Inc.
SMMT
Shares Held
124K
Value
$2.40M
Janux Therapeutics, Inc.
JANX
Shares Held
79K
Value
$2.12M
Cogent Biosciences, Inc.
COGT
Shares Held
29K
Value
$176.65K
Akero Therapeutics, Inc.
AKRO
Shares Held
20K
Value
$806.56K
Soleno Therapeutics, Inc.
SLNO
Shares Held
20K
Value
$1.42M
Insmed Incorporated
INSM
Shares Held
19K
Value
$1.46M
Protagonist Therapeutics, Inc.
PTGX
Shares Held
13K
Value
$621.86K
Regeneron Pharmaceuticals, Inc.
REGN
Shares Held
3K
Value
$1.65M
Ascendis Pharma A/S
ASND
Shares Held
2K
Value
$338.68K
Eli Lilly and Company
LLY
Shares Held
816
Value
$673.94K